Sectoral Asset Management Inc Nektar Therapeutics Transaction History

Sectoral Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$16.59 - $24.79 $442,953 - $661,893	-26,700 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$16.86 - $23.44 $450,162 - $625,848	26,700 New	26,700 $618,000
Q4 2018 Feb 12, 2019	SELL	$30.43 - $56.65 $2.5 Million - $4.66 Million	-82,263 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$46.46 - $68.49 $401,832 - $592,370	8,649 Added 11.75%	82,263 $5.02 Million
Q2 2018 Aug 13, 2018	SELL	$46.25 - $104.45 $1.17 Million - $2.64 Million	-25,300 Reduced 25.58%	73,614 $3.6 Million

Q1 2018 May 15, 2018	SELL	$57.4 - $108.44 $1.08 Million - $2.05 Million	-18,901 Reduced 16.04%	98,914 $10.5 Million
Q4 2017 Feb 13, 2018	BUY	$23.02 - $60.5 $2.71 Million - $7.13 Million	117,815	117,815 $7.04 Million

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $231M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.